FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ipratropium bromide by Hikma Pharmaceuticals USA Inc. under ANDA 076664, updating an already approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Rhinitis

Drugs mentioned

• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

SUPPL AP for IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)